Authors

• Jun Asai (ORCID: https://orcid.org/0000-0002-7610-0820)
• Yukiko Kiniwa (ORCID: https://orcid.org/0000-0003-3757-7375)
• Kazuma Kiyotani (ORCID: https://orcid.org/0000-0002-9236-9061)
• Kohtarou Nagase
• Ryuhei Okuyama (ORCID: https://orcid.org/0000-0003-4360-6865)
• Takehiro Noda (ORCID: https://orcid.org/0000-0002-6768-5783)
• Atsushi Tanemura (ORCID: https://orcid.org/0000-0002-5239-8474)
• Noritaka Tanaka (ORCID: https://orcid.org/0000-0002-6495-540X)
• Takashi Fujimura (ORCID: https://orcid.org/0000-0001-7442-5974)
• Kayo Kunimoto (ORCID: https://orcid.org/0000-0001-8102-1193)
• Hiroshi Yamano- Uchi
• Koji Yoshino
• Yoshihiro Komohara
• Shin Yamazaki (ORCID: https://orcid.org/0000-0002-2309-2425)
• A. Kobayashi
• S. Fukushima
• S. Mori
• T. Maekawa
• H. Kato
• T. Ito
• S. Matsushita
• T. Kimura
• Y. Fujisawa
• H. Yano

Institutions

• Kyushu University (JP)
• Shinshu University (JP)
• University of Tsukuba (JP)
• Jichi Medical University (JP)
• Kumamoto Health Science University (JP)
• Saga University (JP)
• Wakayama Medical University (JP)
• Tohoku University (JP)
• Tokyo Metropolitan Komagome Hospital (JP)
• Nagoya City University (JP)
• Kyoto Prefectural University of Medicine (JP)
• National Institute of Biomedical Innovation, Health and Nutrition (JP)
• National Hospital Organization Kyushu Cancer Center (JP)
• The Cancer Institute Hospital (JP)
• Kagoshima Medical Center (JP)
• Japanese Foundation For Cancer Research (JP)
• Osaka Metropolitan University (JP)
• Nagoya University (JP)
• Tokyo Metropolitan University (JP)
• Kumamoto University (JP)
• The University of Osaka (JP)

Publication Details

Journal

Communications Medicine

Published

2026-01-07

DOI

https://doi.org/10.1038/s43856-025-01341-4

Primary Topic

Cancer Immunotherapy and Biomarkers

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Clinical Trial Center, China Medical University Hospital